In the present study, two cancer cell lines were tested: HCT116 (colorectal carcinoma) and MCF-7 (breast cancer) (American Type Culture Collection, USA). Fetal calf serum (FCS: 10 %) and L-glutamine (2 mM) were used to make complete growth medium to conserve the cell lines (RPMI: Roswell Park Memorial Institute, France). Cell lines were incubated at 37 °C under atmosphere conditions of CO2 (5%). All tests were performed when the cells reached 80% confluence, and a trypan blue exclusion assay was used to test the viability of the cell lines (Louis and Siegel, 2011).
The cytotoxicity of the isolated compounds against HCT116 (colorectal carcinoma) and MCF-7 (breast cancer) cells was evaluated spectrophotometrically through an MTT assay. The assay was performed in 96-well microtiter plates (Bekir et al., 2013). The concentrations of HCT-116 and MCF-7 cells were fixed at 10 × 103 and 12 × 103 cells/well, respectively. The adherent cells were incubated overnight (37 °C) in a 5% enriched CO2 atmosphere. For the cells in the exponential growth phase, further incubation (37 °C) was maintained for 72 h, and the concentration of the tested compounds was 100 μM (DMSO does not exceed 1%). After removing the medium, incubated cells (37 °C) were mixed with 50 μL of MTT solution (3 mg/mL in phosphate-buffered saline, PBS) for 20–40 min. The dissolution of the cell mitochondria and the precipitation of violet formazan crystals proceeded by adding 80 μL of 100% DMSO. The measurement of the obtained reaction was taken spectrophotometrically at 540 nm. As a positive control, Doxorubicin, a conventional anticancer drug, was used. Cell viability was measured using formula II:
where Abs control is the absorbance measured of the total cell activity as described without any inhibition; Abs blank control is the absorbance of MTT substrate; and Abs sample is the absorbance of each inhibitor compound sample.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.